Yahoo Web Search

Sign In

Search results

  1. www.abbvie.comPharmaceutical Research & Development | AbbVie

    AbbVie is a global biopharmaceutical company that invests in science and innovation to treat 75+ conditions and improve health care for all. Learn about AbbVie's R&D, partnerships, sustainability, careers and investor resources.

    • Join Us

      As a result, the site may contain information on...

    • Products

      Please contact your local AbbVie office to learn more about...

    • Investor Overview

      AbbVie is a global biopharmaceutical company with focus and...

    • Who We Are

      AbbVie was founded in 2013 when we became a separate company...

    • Pipeline

      Pharmaceuticals. Molecule/Asset Phase Phase 1. Phase 2....

    • Partner with Us

      AbbVie Neuroscience portfolio consists of approved therapies...

    • Patient Support

      AbbVie help patients get the medicines and solutions they...

    • Latest News

      AbbVie (NYSE: ABBV) will announce its second-quarter 2024...

  2. Videos

    View all

  3. en.wikipedia.org › wiki › AbbVieAbbVie - Wikipedia

    AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74.

  4. news.abbvie.com › 2023/11/30-AbbVie-to-Acquire-ImmunoGenAbbVie to Acquire ImmunoGen, including its Flagship Cancer...

    Nov 30, 2023 · The acquisition accelerates AbbVie's commercial and clinical presence in the solid tumor space. Additionally, ImmunoGen's follow-on pipeline of promising next-generation ADCs further complements AbbVie's ADC platform and existing programs.

  5. www.abbvie.co.uk › our-companyOur Company | AbbVie

    AbbVie is a company that invests in research and innovation to discover and deliver new medicines for various health challenges. Learn about its history, mission, values, and careers in immunology, oncology, neuroscience, and more.

  6. news.abbvie.com › 2020/05/08-AbbVie-Completes-TransformativeAbbVie Completes Transformative Acquisition of Allergan

    May 8, 2020 · May 08, 2020. AbbVie Completes Transformative Acquisition of Allergan. - Creates biopharmaceutical company with leadership positions in key therapeutic areas: Immunology, Hematologic Oncology, Neuroscience, and Allergan Aesthetics. - Robust portfolio of on-market and pipeline assets well-positioned for sustainable long-term growth.

  7. investors.abbvie.comInvestor Overview | AbbVie

    AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world's greatest health challenges. AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's lives.

  8. www.linkedin.com › company › abbvieAbbVie | LinkedIn

    AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues...